Format

Send to

Choose Destination
J Manag Care Spec Pharm. 2016 Jun;22(6):676-84. doi: 10.18553/jmcp.2016.22.6.676.

Pillbox Use and INR Stability in a Prospective Cohort of New Warfarin Users.

Author information

1
1 Faculty of Pharmacy, Université de Montréal, and Montreal Heart Institute, Beaulieu-Saucier Université de Montréal Pharmacogenomics Centre, Montreal, Quebec, Canada.
2
2 Montreal Heart Institute, Beaulieu-Saucier Université de Montréal Pharmacogenomics Centre, and Faculty of Medicine, Department of Pharmacology, Université de Montréal, Quebec, Canada.
3
3 Faculty of Pharmacy, Université de Montréal, Quebec, Canada.
4
4 Montreal Heart Institute, Beaulieu-Saucier Université de Montréal Pharmacogenomics Centre, and Faculty of Medicine, Department of Medicine, Université de Montréal, Quebec, Canada.
5
5 Montreal Heart Institute, Beaulieu-Saucier Université de Montréal Pharmacogenomics Centre, and Faculty of Medicine, Department of Medicine, Université de Montréal, Quebec, Canada.
6
7 Montreal Heart Institute, Beaulieu-Saucier Université de Montréal Pharmacogenomics Centre, Montreal, Quebec, Canada.
7
6 Montreal Heart Institute, Beaulieu-Saucier Université de Montréal Pharmacogenomics Centre, and Faculty of Medicine, Department of Medicine, Université de Montréal, Quebec, Canada.

Abstract

BACKGROUND:

Warfarin, a frequently prescribed oral anticoagulant, is well known for its narrow therapeutic index. Adherence to warfarin may help to achieve a stable international normalized ratio (INR), but little data are available regarding the impact of using a pillbox as a potential adherence aid device.

OBJECTIVE:

To evaluate the association between pillbox use and time in therapeutic range (TTR) < 60% and INR instability pattern.

METHODS:

This study was based on a prospective cohort of 1,069 new warfarin users who initiated warfarin between May 2010 and July 2013 within 17 hospitals in Quebec, Canada. Demographic, lifestyle, and clinical data were collected for 3 months to a year after warfarin initiation, and genetic factors were assessed. Patients usingh self-prepared and pharmacist-prepared pillboxes were compared with nonusers for the 3- to 12-month follow-up period. The primary outcome was a TTR < 60%, which represents a low percentage of time in the INR therapeutic range or an unstable patient. The secondary outcome was the INR instability pattern (unstable below range; unstable over range; unstable with erratic pattern; and stable) to better describe patient INR profiles. A multivariate generalized linear mixed model was used for the primary outcome, along with a multivariate multinomial linear mixed model for the secondary outcome.

RESULTS:

The cohort included patients with a mean age of 70.4 ± 11.7 years; 61.8% of patients were men; 76.3% had atrial fibrillation as warfarin's primary indication; and 35.6% had a previous history of myocardial infarction or angina. Self-prepared and pharmacist-prepared pillbox use was not associated with TTR < 60% or a specific INR instability pattern. A sensitivity analysis showed that self-prepared pillbox users had a higher TTR than nonusers (3.55% ± 1.69%; P = 0.036). This effect was greater among patients aged < 70 years (5.48% ± 2.50%; P = 0.029) than among older patients (1.92% ± 2.31%; P =0.406).

CONCLUSIONS:

Pillbox use was not associated with TTR < 60% or a specific INR instability pattern. The impact of self-prepared pillbox use was greater among younger patients, but results were not clinically significant. Future studies adjusting for concomitant drug use are needed to clarify these results.

DISCLOSURES:

This study was funded by Canadian Institutes of Health Research (CIHR) and the Centre for Excellence in Personalised Medicine. Both funding sources were not involved in the design, conduct, and reporting of this study. The data used for this study came from the Quebec Warfarin Cohort Study (QWCS), which was supported by the CIHR and the Centre for Excellence in Personalised Medicine. Dumas received a doctoral training award from the CIHR. Perreault and Dubé received a salary award from the Fonds Québécois de Recherche en Santé. Study concept and design were contributed by Talajic, Tardif, Dubé, and Perreault. Dumas, Rouleau-Mailloux, Bouchama, and Lahcene collected the data, which was interpreted by Dumas, Dubé, and Perreault. The manuscript was written and revised by Dumas, Dubé, and Perreault.

PMID:
27231795
DOI:
10.18553/jmcp.2016.22.6.676
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Academy of Managed Care Pharmacy
Loading ...
Support Center